Dihydroergotamine mesylate
HealthData.Gov
Updated Mar 24, 2026
About this dataset
Dihydroergotamine Mesylate is a prescription nasal spray used to relieve migraine headaches. Each spray delivers 0.5 mg of the active ingredient. Manufactured by Trifluent Pharma, LLC under FDA application ANDA216881. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Dihydroergotamine mesylate
Access the FDA dataset for Dihydroergotamine mesylate — ANDA 215623 submitted by Mylan Institutional LLC
Modified Mar 24, 2026